Herpes Zoster: Clinical Aspects and Prevention Strategies for Patients With Immune-mediated Diseases

1.00 CME
0.75 AANP
60 MINS
$0 FEE
SAVE
rheum cme

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.


Support Statement

This educational activity is supported by an educational grant from GlaxoSmithKline.


Activity Description

Shingles, also called herpes zoster (HZ), is a painful rash that develops due to reactivation of the varicella zoster virus, which causes chicken pox. Approximately 1 in 3 individuals in the United States will develop shingles during their lifetime, with adults over 50 years of age and immunocompromised individuals being at highest risk. Recent developments in HZ prevention include a new recombinant zoster vaccine, which is now recommended as the preferred shingles vaccine in updated guidelines from the Advisory Committee on Immunization Practices (ACIP). Education regarding the most up-to-date guidelines, as well as prevention and management strategies, is essential to help prevent the potential sequelae of HZ, which can include post-herpetic neuralgia, ophthalmic involvement, and increased risk of stroke. Effective prevention and risk management strategies are particularly important for patients with immune-mediated diseases. In this CME program, experts will review the clinical aspects and primary risk factors for HZ, discuss optimized use of vaccines for at-risk populations, and provide guidance on effective patient education strategies to enhance vaccine uptake.  


Target Audience

The intended audience for this activity is rheumatologists, gastroenterologists, dermatologists, physician assistants, nurse practitioners, and other health care professionals involved in the management of patients at risk for herpes zoster.


Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Identify the clinical aspects and primary risk factors for herpes zoster (HZ) to enhance the use of vaccines in patients who are at high risk for infection.
  • Implement effective prevention strategies and patient education to increase herpes zoster vaccine uptake and compliance.

Activity Chair

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinic
Cleveland, OH


Faculty

Cassandra Calabrese, DO
Rheumatology and Infectious Disease
Cleveland Clinic Foundation
Cleveland, OH

Jeffrey R. Curtis MD, MS, MPH
Marguerite Jones Harbert – Gene Ball Endowed Professor of Medicine
Co-Director, PharmacoEpidemiology & Economic Research PEER-Group
University of Alabama at Birmingham
Birmingham, AL

Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, MA


Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP 
Linda A. Giarraputo PA-C


Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

aanpThis activity is approved for 0.75 contact hour(s) of continuing education (which includes 0.75 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 20094501. This activity was planned in accordance with AANP Accreditation Standards and Policies.

aapaThis activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid from 9/30/2020 to 9/29/2021. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-201159.

This enduring material is approved for 1 year from the date of original release, September 30, 2020 to September 29, 2021. 


How to Participate in This Activity and Obtain CME Credit

To participate in this CE activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest, and complete and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 out of 4 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate, AAPA Category 1 CME certificate, or Contact Hours certificate. 


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.  

Activity Chair and Faculty report the following relationship(s)

Cassandra Calabrese, DO
Consulting Fee: AbbVie
Speakers Bureau: Regeneron

Leonard H. Calabrese, DO
Consulting Fee: AbbVie, Amgen, Bristol-Myers Squibb, Crescendo, Genentech, Gilead, GlaxoSmithKline, Horizon, Janssen, Kiniksa, Lilly, Pfizer, Sanofi-Regeneron, UCB
Speakers Bureau: AbbVie, Bristol-Myers Squibb, Crescendo, Genentech, Horizon, Sanofi, UCB

Jeffrey R. Curtis MD, MS, MPH
Consulting Fee: AbbVie, Amgen, Bristol-Myers Squibb, Corrona, Lilly, Gilead, GlaxoSmithKline, Janssen, Myriad, Pfizer, Radius, Sanofi, UCB
Contracted Research: Amgen, Bristol-Myers Squibb, Corrona, Lilly, Janssen, Myriad, Pfizer, Radius

Paul E. Sax, MD
Consulting Fee: Gilead, GlaxoSmithKline/ViiV, Janssen, Merck
Contracted Research: Gilead, GlaxoSmithKline/ViiV, Merck
Editorial Positions: Medscape, NEJM Journal Watch, Open Forum Infectious Diseases, UpToDate

Reviewers report the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose. 

Linda A. Giarraputo PA-C
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non—FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com